New Vice Chair named for NRG Health Disparities Committee (HDC)

October 24 2023

Evan M. Graboyes, MD, MPH is an Associate Professor in the Departments of Otolaryngology-Head & Neck Surgery and Public Health Sciences at the Medical University of South Carolina (MUSC) where he is the Director of Survivorship and Cancer Outcomes Research (SCOR) at the NCI-designated Hollings Cancer Center. He is an active member of the HDC, Co-Chairing the HDC’s Research Concept Development Special Interest Group with outgoing HDC Vice Chair, Chanita Hughes-Halbert since 2022.

Dr. Graboyes has dedicated his professional career as a cancer surgeon and health services researcher to understanding and addressing issues related to cancer disparities, cancer care delivery, and health-related social risks among patients with cancer along the treatment continuum. He has led multiple NCI-funded randomized clinical trials and foundation awards evaluating supportive care and equity-focused health services interventions in patients with cancer. In addition to his service with NRG Oncology, Dr. Graboyes is an active contributor to cancer disparities, cancer care delivery, and survivorship research and initiatives at the National Cancer Institute, the American Society of Clinical Oncology, the American Head and Neck Society, and the Commission on Cancer.

Dr. Graboyes's appointment as Vice Chair of the NRG Oncology's Health Disparities Committee will enhance NRG Oncology's capacity to incorporate health disparities research within NRG clinical trials through concept development and resulting protocols, as well as the creation of ancillary studies.Through this new appointment he will also help to expand the HDC health disparities educational and mentoring efforts through the NRG NCORP and NCTN programs.

We are delighted to officially welcome Dr. Graboyes in his new role as Vice-Chair, recognizing his ongoing commitment to the HDC and to NRG Oncology as well as the many contributions of his NRG Mentor, Dr. Chanita Hughes-Halbert.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.